Equities
Health CareMedical Equipment and Services
  • Price (USD)254.23
  • Today's Change1.72 / 0.68%
  • Shares traded1.04m
  • 1 Year change+7.28%
  • Beta0.5919
Data delayed at least 15 minutes, as of Aug 05 2022 21:10 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through three business segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

  • Revenue in USD (TTM)19.24bn
  • Net income in USD1.52bn
  • Incorporated1906
  • Employees75.00k
  • Location
    Becton Dickinson and CoOne Becton DriveFRANKLIN LAKES 07417-1880United StatesUSA
  • Phone+1 (201) 847-6800
  • Websitehttps://www.bd.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
BDX:NYQ since
announced
Transaction
value
Parata Systems LLCDeal completed06 Jun 202206 Jun 2022Deal completed0.75%1.53bn
Cytognos SLDeal completed31 Jan 202231 Jan 2022Deal completed-0.59%--
Scanwell Health IncDeal completed21 Dec 202121 Dec 2021Deal completed0.72%--
Tissuemed LtdDeal completed09 Dec 202109 Dec 2021Deal completed3.16%--
Venclose IncDeal completed02 Dec 202102 Dec 2021Deal completed5.20%--
Data delayed at least 15 minutes, as of Aug 05 2022 21:10 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Boston Scientific Corporation12.33bn828.00m58.53bn41.00k71.03--31.334.750.57630.57638.58--------300,707.30--3.26--4.0068.4869.407.168.03--6.27--0.0019.927.23956.5223.201.75--
Edwards Lifesciences Corp5.36bn1.46bn65.79bn15.70k45.9211.0741.3612.292.312.318.509.590.66581.598.39341,082.8018.0915.9920.4518.9577.7875.1127.1823.632.60--0.09110.0019.2912.0482.5521.428.69--
Becton Dickinson and Co19.24bn1.52bn72.47bn75.00k48.042.8419.263.775.295.7966.9189.390.35793.468.96256,586.703.002.613.482.9645.1446.638.387.490.90175.360.39172.7918.2910.16161.0215.4511.394.69
Stryker Corporation17.63bn2.08bn81.64bn46.00k39.695.2126.794.635.445.4446.0941.430.50561.736.02383,239.105.966.736.817.9564.8565.5711.7913.161.15--0.460542.3919.218.6024.703.901.3911.20
Intuitive Surgical, Inc.5.96bn1.43bn85.82bn9.79k61.397.1447.3814.393.913.9116.2833.670.45872.947.75608,986.0011.1814.1212.2515.6868.1668.8324.3629.384.74--0.000.0031.0116.1060.7218.2245.67--
Data as of Aug 05 2022. Currency figures normalised to Becton Dickinson and Co's reporting currency: US Dollar USD

Institutional shareholders

39.37%Per cent of shares held by top holders
HolderShares% Held
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 202225.15m8.82%
The Vanguard Group, Inc.as of 31 Mar 202223.36m8.20%
BlackRock Fund Advisorsas of 31 Mar 202214.04m4.93%
SSgA Funds Management, Inc.as of 31 Mar 202212.58m4.41%
Wellington Management Co. LLPas of 31 Mar 202211.35m3.98%
Morgan Stanley Investment Management Ltd.as of 31 Mar 20226.68m2.34%
Parnassus Investments LLCas of 30 Jun 20225.45m1.91%
Geode Capital Management LLCas of 31 Mar 20224.61m1.62%
Generation Investment Management LLPas of 31 Mar 20224.50m1.58%
Massachusetts Financial Services Co.as of 31 Mar 20224.49m1.58%
More ▼
Data from 31 Mar 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.